{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:18:57Z","timestamp":1791245937213,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1827,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jto.0b013e3181fd418d","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T05:44:12Z","timestamp":1287812652000},"page":"1933-1938","source":"Crossref","is-referenced-by-count":47,"title":["Association of Epidermal Growth Factor Receptor Activating Mutations with Low ERCC1 Gene Expression in Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"David R.","family":"Gandara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Grimminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Primo N.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Danenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen D.","family":"Danenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181fd418d_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO.1988.6.4.633","article-title":"Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer\u2014report of a Canadian multicenter randomized trial","volume":"6","author":"Rapp","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib2","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1200\/JCO.1999.17.10.3188","article-title":"Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life","volume":"17","author":"Cullen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib4","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib5","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancer from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib7","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1200\/JCO.2005.01.0793","article-title":"Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer","volume":"23","author":"Takano","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib10","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2009.27.15_suppl.8016","article-title":"First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: a phase III study (002) by North East Japan Gefitinib Study Group","volume":"27","author":"Kobayashi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-8-210","article-title":"Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer","volume":"8","author":"Makino","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-60327-040-3_8","article-title":"Design and use of scorpions fluorescent signaling molecules","volume":"429","author":"Carters","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/JTO.0b013e3181bbf239","article-title":"EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer","volume":"4","author":"Mack","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib15","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.7513","article-title":"Histology-and gender-related associations of ERCC1, RRM1 and TS biomarkers in 1,802 patients with NSCLC: implications for therapy","volume":"28","author":"Gandara","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib16","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2006.09.7915","article-title":"Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer","volume":"25","author":"Cobo","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","article-title":"DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer","volume":"356","author":"Zheng","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","article-title":"ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer","volume":"127","author":"Simon","year":"2005","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib20","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib21","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/annonc\/mdl300","article-title":"ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine","volume":"17","author":"Ceppi","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib22","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1158\/1078-0432.CCR-09-0888","article-title":"Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials","volume":"15","author":"Jackman","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib23","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib24","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1158\/0008-5472.CAN-08-1127","article-title":"Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib25","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1074\/jbc.273.3.1568","article-title":"Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells","volume":"273","author":"Bandyopadhyay","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib26","doi-asserted-by":"crossref","first-page":"e5133","DOI":"10.1371\/journal.pone.0005133","article-title":"Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression","volume":"4","author":"Rosell","year":"2009","journal-title":"PLoS One"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/89.5.365","article-title":"Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA","volume":"89","author":"Dixit","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.1101637","article-title":"Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways","volume":"305","author":"Sordella","year":"2004","journal-title":"Science"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib29","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1158\/0008-5472.CAN-06-2627","article-title":"Non-small cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation","volume":"66","author":"Das","year":"2006","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib30","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1158\/1078-0432.CCR-07-1610","article-title":"The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage","volume":"13","author":"Chen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib31","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1200\/jco.2010.28.15_suppl.7016","article-title":"Thoracic radiation therapy in locally advanced NSCLC patients (pts) with EGFR mutations","volume":"28","author":"Mak","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1078-0432.CCR-05-1846","article-title":"Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon19 and exon 21 mutations treated with gefitinib or erlotinib","volume":"12","author":"Riely","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib33","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-06-0462","article-title":"Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib","volume":"12","author":"Jackman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/JTO.0b013e318074bc0d","article-title":"Clinical significance of epidermal growth factor receptor gene mutations on treatment outcome after first-line cytotoxic chemotherapy in Japanese patients with non-small cell lung cancer","volume":"2","author":"Hotta","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib35","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.1200\/JCO.2005.02.7078","article-title":"Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL\/INTACT gefitinib trials","volume":"23","author":"Bell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2009.04.018","article-title":"Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer","volume":"67","author":"Wu","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ijc.24657","article-title":"Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer","volume":"126","author":"Wu","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e3181fd418d_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lungcan.2007.10.014","article-title":"ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer","volume":"60","author":"Lee","year":"2008","journal-title":"Lung Cancer"},{"issue":"Suppl","key":"10.1097\/JTO.0b013e3181fd418d_bib39","article-title":"A randomized phase III study of gefitinib versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokers with advanced or metastatic adenocarcinoma of the lung","volume":"4","author":"Lee","year":"2009","journal-title":"J Thorac Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415318645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415318645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T14:56:17Z","timestamp":1636728977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415318645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1556086415318645"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181fd418d","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}